Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 26.28M | 22.62M | 25.14M | 25.00M | 24.40M | 28.25M |
Gross Profit | 10.90M | 9.87M | 10.20M | 11.07M | 11.59M | 10.83M |
EBITDA | -3.59M | -4.01M | -3.91M | -1.90M | -752.32K | -5.65M |
Net Income | -4.24M | -4.76M | -4.60M | -2.45M | 3.70M | -6.15M |
Balance Sheet | ||||||
Total Assets | 28.35M | 31.09M | 27.79M | 28.25M | 32.36M | 30.07M |
Cash, Cash Equivalents and Short-Term Investments | 1.64M | 5.41M | 1.35M | 1.91M | 3.61M | 1.49M |
Total Debt | 3.69M | 3.73M | 1.48M | 1.31M | 1.96M | 3.60M |
Total Liabilities | 19.41M | 20.97M | 13.14M | 9.27M | 11.23M | 12.81M |
Stockholders Equity | 9.10M | 10.23M | 14.75M | 19.09M | 21.21M | 17.31M |
Cash Flow | ||||||
Free Cash Flow | -495.89K | 3.09M | -870.17K | -1.70M | 310.49K | 1.22M |
Operating Cash Flow | 194.63K | 4.06M | -823.32K | -1.35M | 465.03K | 1.41M |
Investing Cash Flow | -766.33K | -1.01M | -244.89K | -348.56K | -215.06K | -217.76K |
Financing Cash Flow | 1.37M | 1.01M | 505.50K | -76.84K | 1.87M | -576.93K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
59 Neutral | 48.04M | -6.29 | 99.63% | ― | -19.60% | -483.35% | |
55 Neutral | 63.98M | -9.51 | 123.50% | ― | 9.22% | 20.66% | |
51 Neutral | 255.13M | -0.86 | -36.15% | ― | 78.82% | -20.81% | |
47 Neutral | $233.07M | ― | -39.83% | ― | 9.84% | 15.29% | |
43 Neutral | 23.28M | -0.26 | -2271.61% | ― | -16.98% | 2.43% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
Tecogen Inc., a Delaware corporation, approved the prepayment of two promissory notes totaling $1 million, originally issued to John N. Hatsopoulos, a company director. The prepayments, made on September 3 and 4, 2025, amounted to $1,076,955.62, including interest, and eliminated the company’s outstanding debt and future interest charges of approximately $46,159.
The most recent analyst rating on (TGEN) stock is a Hold with a $10.00 price target. To see the full list of analyst forecasts on Tecogen stock, see the TGEN Stock Forecast page.
Tecogen reported its second quarter 2025 financial results, showing a revenue increase to $7.29 million from $4.73 million in 2024, despite a net loss of $1.47 million. The company highlighted progress in its data center strategy, with a significant pilot project underway, and noted challenges such as reduced gross profit margins due to initial costs of new products and regional service issues. Tecogen also raised $18.2 million in July to enhance manufacturing and marketing efforts, aiming to scale up operations and capitalize on potential large-scale projects.
On July 28, 2025, Tecogen Inc. announced the appointment of Roger Deschenes as Chief Financial Officer and Treasurer. Deschenes, who has been with the company for five years as Chief Accounting Officer, brings extensive public company experience to his new role. This appointment is seen as a strategic move to enhance Tecogen’s financial systems and support its growth. Additionally, on July 24, 2025, Tecogen’s Board of Directors authorized Dr. Rangesh to issue stock options to non-executive employees, with a total value not exceeding $200,000, to incentivize and retain talent.
On July 21, 2025, Tecogen Inc. announced the closing of an underwritten public offering of 3,985,000 shares of common stock at $5.00 per share, raising approximately $18,160,750 in net proceeds. The company plans to use the funds for product development, sales and marketing activities, human resources, capital expenditures, and expansion into the data center market, which could enhance its market positioning and operational capabilities.